A Clinical-Stage Biotech Company
CellKure
Revolutionizing Cancer Treatment with Advanced, Multi-Targeted Immunotherapies
Transforming Cancer Care
At CellKure, we are pioneering the next evolution in T-cell therapy, harnessing the immune system to fight aggressive cancers. Our breakthrough platform provides a durable and scalable solution, starting with acute myeloid leukemia (AML) and expanding into solid tumors.
Scalable & Efficient Manufacturing
Simplified production for widespread accessibility
Multi-Antigen Targeting
Broad tumor recognition to reduce resistance
Natural T-Cell Activation
No genetic modifications required
Minimized Patient Burden
Designed for a streamlined treatment experience
Our Platform
Advancing T-Cell Therapy
CellKure’s technology represents a significant leap forward in cellular immunotherapy, improving effectiveness, safety, and scalability.
-
Key Advantages
- ✔ Multi-Antigen Targeting – Broad tumor recognition to reduce resistance
- ✔ Natural T-Cell Activation – No genetic modifications required
- ✔ Scalable & Efficient – Simplified production for widespread accessibility
- ✔ Minimized Patient Burden – Designed for a streamlined treatment experience
-
How It Works
- Our proprietary platform activates T-cells in a way that enhances their ability to detect and eliminate cancer, while maintaining long-term immune surveillance to help prevent relapse.
Our Platform
Advancing T-Cell Therapy
CellKure’s technology represents a significant leap forward in cellular immunotherapy, improving effectiveness, safety, and scalability.
-
Key Advantages
- ✔ Multi-Antigen Targeting – Broad tumor recognition to reduce resistance
- ✔ Natural T-Cell Activation – No genetic modifications required
- ✔ Scalable & Efficient – Simplified production for widespread accessibility
- ✔ Minimized Patient Burden – Designed for a streamlined treatment experience
-
How It Works
- Our proprietary platform activates T-cells in a way that enhances their ability to detect and eliminate cancer, while maintaining long-term immune surveillance to help prevent relapse.
How CellKure is Changing the Landscape
Our vision extends beyond AML, with our platform designed for future applications in solid tumors and autoimmune diseases.
Targeting High-Risk Patients
Addressing critical unmet needs.
Precision-Driven Approach
Enhancing natural immune responses.
Strategic Development
Advancing through clinical milestones toward regulatory approval.